- Published on
Emergency and Acute Medicine: Bee Sting (Hymenoptera Envenomation)
Bee stings are a common form of envenomation caused by insects from the order Hymenoptera, which includes bees, wasps, hornets, and fire ants. Their venom triggers the release of biologically active substances that can produce a range of reactions, from mild local irritation to life-threatening systemic responses. Most reactions are IgE-mediated type I hypersensitivity reactions, although less commonly, delayed immune responses such as type III (Arthus) reactions may occur.
Clinical presentation varies widely depending on the individual’s immune response and the amount of venom delivered. The most common reaction is a localized response, characterized by immediate pain, redness, and swelling at the sting site, typically resolving within a few hours. Larger local reactions may involve an entire limb, peak within 48 hours, and persist for several days, sometimes accompanied by mild fever.
Systemic reactions represent true allergic responses and can progress to anaphylaxis, which is potentially fatal. Symptoms usually develop within 15–20 minutes and may include respiratory distress (wheezing, stridor, shortness of breath), cardiovascular instability (hypotension, tachycardia, shock), gastrointestinal symptoms (nausea, vomiting, diarrhea), and skin manifestations such as urticaria, flushing, and angioedema. Toxic reactions can occur after multiple stings due to a large venom load and may mimic anaphylaxis. Rare delayed or unusual immune-mediated complications include vasculitis, nephropathy, serum sickness, and neurologic involvement.
Diagnosis is primarily clinical, based on history and physical examination. There are no specific laboratory or imaging tests required for uncomplicated cases. However, investigations such as blood tests or ECG may be warranted in patients with significant systemic involvement, particularly those with underlying cardiovascular disease.
Management depends on the severity of the reaction. Immediate priorities in severe systemic reactions include airway stabilization, oxygen administration, intravenous access, and prompt use of epinephrine, which is the first-line treatment for anaphylaxis. Antihistamines (both H1 and H2 blockers), corticosteroids, and inhaled β-agonists are used as adjunct therapies. Persistent hypotension requires aggressive fluid resuscitation and possibly vasopressor support.
For local reactions, treatment is supportive and includes removal of the stinger (preferably by scraping rather than squeezing to avoid further venom release), application of cold compresses, limb elevation, and use of oral or topical antihistamines or corticosteroids. Pain control and avoidance of constrictive items such as rings or tight clothing are also important.
Patients with systemic reactions should be observed for at least 6 hours, while those with severe or life-threatening reactions may require admission and prolonged monitoring. Discharge is appropriate for patients with mild local reactions or resolved systemic symptoms after observation. Importantly, individuals who experience systemic reactions should be prescribed an epinephrine auto-injector and referred to an allergist for further evaluation and possible immunotherapy.
A key clinical point is that most fatal outcomes occur within the first hour due to airway compromise or circulatory collapse. Rapid recognition and early administration of epinephrine are critical. Patients with a history of severe reactions must be educated on avoidance strategies and emergency self-treatment to reduce the risk of recurrence.
Bee stings are a common form of envenomation caused by insects from the order Hymenoptera, which includes bees, wasps, hornets, and fire ants. Their venom triggers the release of biologically active substances that can produce a range of reactions, from mild local irritation to life-threatening systemic responses. Most reactions are IgE-mediated type I hypersensitivity reactions, although less commonly, delayed immune responses such as type III (Arthus) reactions may occur.
Clinical presentation varies widely depending on the individual’s immune response and the amount of venom delivered. The most common reaction is a localized response, characterized by immediate pain, redness, and swelling at the sting site, typically resolving within a few hours. Larger local reactions may involve an entire limb, peak within 48 hours, and persist for several days, sometimes accompanied by mild fever.
Systemic reactions represent true allergic responses and can progress to anaphylaxis, which is potentially fatal. Symptoms usually develop within 15–20 minutes and may include respiratory distress (wheezing, stridor, shortness of breath), cardiovascular instability (hypotension, tachycardia, shock), gastrointestinal symptoms (nausea, vomiting, diarrhea), and skin manifestations such as urticaria, flushing, and angioedema. Toxic reactions can occur after multiple stings due to a large venom load and may mimic anaphylaxis. Rare delayed or unusual immune-mediated complications include vasculitis, nephropathy, serum sickness, and neurologic involvement.
Diagnosis is primarily clinical, based on history and physical examination. There are no specific laboratory or imaging tests required for uncomplicated cases. However, investigations such as blood tests or ECG may be warranted in patients with significant systemic involvement, particularly those with underlying cardiovascular disease.
Management depends on the severity of the reaction. Immediate priorities in severe systemic reactions include airway stabilization, oxygen administration, intravenous access, and prompt use of epinephrine, which is the first-line treatment for anaphylaxis. Antihistamines (both H1 and H2 blockers), corticosteroids, and inhaled β-agonists are used as adjunct therapies. Persistent hypotension requires aggressive fluid resuscitation and possibly vasopressor support.
For local reactions, treatment is supportive and includes removal of the stinger (preferably by scraping rather than squeezing to avoid further venom release), application of cold compresses, limb elevation, and use of oral or topical antihistamines or corticosteroids. Pain control and avoidance of constrictive items such as rings or tight clothing are also important.
Patients with systemic reactions should be observed for at least 6 hours, while those with severe or life-threatening reactions may require admission and prolonged monitoring. Discharge is appropriate for patients with mild local reactions or resolved systemic symptoms after observation. Importantly, individuals who experience systemic reactions should be prescribed an epinephrine auto-injector and referred to an allergist for further evaluation and possible immunotherapy.
A key clinical point is that most fatal outcomes occur within the first hour due to airway compromise or circulatory collapse. Rapid recognition and early administration of epinephrine are critical. Patients with a history of severe reactions must be educated on avoidance strategies and emergency self-treatment to reduce the risk of recurrence.
- Published on
Emergency and Acute Medicine: Stevens–Johnson Syndrome
Stevens–Johnson syndrome (SJS) is a rare but severe mucocutaneous disorder characterized by widespread skin and mucosal injury. It involves blistering and epidermal detachment affecting less than 10% of the body surface area, distinguishing it from more extensive conditions such as toxic epidermal necrolysis. The disease almost always involves mucous membranes, typically affecting at least two sites such as the oral cavity, eyes, or genitalia. Skin lesions often begin on the face, neck, and trunk and may rapidly become confluent over hours to days. Although part of a spectrum with toxic epidermal necrolysis, SJS is considered a distinct clinical entity.
The condition is most commonly triggered by medications or infections. Drugs such as antibiotics (especially sulfonamides and penicillins), anticonvulsants, nonsteroidal anti-inflammatory drugs, and allopurinol are frequent culprits. Infectious causes include Mycoplasma pneumoniae and herpes simplex virus. The underlying mechanism involves an immune-mediated process in which cytotoxic T cells target keratinocytes expressing drug-related antigens, leading to widespread apoptosis of skin cells and systemic inflammation.
Patients typically present with a prodrome resembling a viral illness, occurring one to three days before the rash. Symptoms include fever, malaise, headache, upper respiratory symptoms, and sometimes joint or muscle pain. This is followed by skin tenderness, burning, and the development of erythematous or purpuric macules that may evolve into target-like lesions or flaccid blisters. These lesions can detach with slight pressure, demonstrating the Nikolsky sign. Painful mucosal involvement is a hallmark feature, leading to symptoms such as difficulty swallowing, urination discomfort, and eye irritation or conjunctivitis. Ocular involvement is common and may progress to serious complications such as corneal damage.
Diagnosis is primarily clinical and based on history, examination, and the extent of skin involvement. A careful medication history is crucial, as symptoms typically develop within two weeks of drug exposure, or more rapidly upon re-exposure. Laboratory tests may reveal nonspecific findings such as anemia or lymphopenia, while skin biopsy can confirm the diagnosis by showing full-thickness epidermal necrosis and subepidermal separation.
Management focuses on early recognition, withdrawal of the offending agent, and supportive care. Patients should be treated similarly to burn victims, especially those with significant skin involvement. Fluid resuscitation is essential due to fluid losses from denuded skin. Pain control is critical, as mucosal lesions can be extremely painful. Monitoring and treatment of secondary infections are vital, as sepsis—particularly from gram-negative organisms—is the leading cause of death. Advanced therapies such as intravenous immunoglobulin or corticosteroids may be considered, although their use remains controversial.
All patients with SJS require hospital admission, and those with extensive skin involvement should be managed in a burn unit or intensive care setting. Airway protection and ventilatory support may be necessary in severe cases. Long-term follow-up is important, particularly for ocular and dermatologic complications. Patients must be clearly educated about the causative drug and advised to avoid it permanently, as re-exposure can lead to rapid and more severe recurrence.
A key challenge is early recognition, as SJS often begins with nonspecific flu-like symptoms. Clinicians must maintain a high index of suspicion in patients presenting with mucocutaneous lesions and recent drug exposure. Prompt diagnosis and aggressive supportive care significantly improve outcomes.
Stevens–Johnson syndrome (SJS) is a rare but severe mucocutaneous disorder characterized by widespread skin and mucosal injury. It involves blistering and epidermal detachment affecting less than 10% of the body surface area, distinguishing it from more extensive conditions such as toxic epidermal necrolysis. The disease almost always involves mucous membranes, typically affecting at least two sites such as the oral cavity, eyes, or genitalia. Skin lesions often begin on the face, neck, and trunk and may rapidly become confluent over hours to days. Although part of a spectrum with toxic epidermal necrolysis, SJS is considered a distinct clinical entity.
The condition is most commonly triggered by medications or infections. Drugs such as antibiotics (especially sulfonamides and penicillins), anticonvulsants, nonsteroidal anti-inflammatory drugs, and allopurinol are frequent culprits. Infectious causes include Mycoplasma pneumoniae and herpes simplex virus. The underlying mechanism involves an immune-mediated process in which cytotoxic T cells target keratinocytes expressing drug-related antigens, leading to widespread apoptosis of skin cells and systemic inflammation.
Patients typically present with a prodrome resembling a viral illness, occurring one to three days before the rash. Symptoms include fever, malaise, headache, upper respiratory symptoms, and sometimes joint or muscle pain. This is followed by skin tenderness, burning, and the development of erythematous or purpuric macules that may evolve into target-like lesions or flaccid blisters. These lesions can detach with slight pressure, demonstrating the Nikolsky sign. Painful mucosal involvement is a hallmark feature, leading to symptoms such as difficulty swallowing, urination discomfort, and eye irritation or conjunctivitis. Ocular involvement is common and may progress to serious complications such as corneal damage.
Diagnosis is primarily clinical and based on history, examination, and the extent of skin involvement. A careful medication history is crucial, as symptoms typically develop within two weeks of drug exposure, or more rapidly upon re-exposure. Laboratory tests may reveal nonspecific findings such as anemia or lymphopenia, while skin biopsy can confirm the diagnosis by showing full-thickness epidermal necrosis and subepidermal separation.
Management focuses on early recognition, withdrawal of the offending agent, and supportive care. Patients should be treated similarly to burn victims, especially those with significant skin involvement. Fluid resuscitation is essential due to fluid losses from denuded skin. Pain control is critical, as mucosal lesions can be extremely painful. Monitoring and treatment of secondary infections are vital, as sepsis—particularly from gram-negative organisms—is the leading cause of death. Advanced therapies such as intravenous immunoglobulin or corticosteroids may be considered, although their use remains controversial.
All patients with SJS require hospital admission, and those with extensive skin involvement should be managed in a burn unit or intensive care setting. Airway protection and ventilatory support may be necessary in severe cases. Long-term follow-up is important, particularly for ocular and dermatologic complications. Patients must be clearly educated about the causative drug and advised to avoid it permanently, as re-exposure can lead to rapid and more severe recurrence.
A key challenge is early recognition, as SJS often begins with nonspecific flu-like symptoms. Clinicians must maintain a high index of suspicion in patients presenting with mucocutaneous lesions and recent drug exposure. Prompt diagnosis and aggressive supportive care significantly improve outcomes.
- Published on
Emergency and Acute Medicine: Sporotrichosis
Sporotrichosis is a subacute or chronic fungal infection caused by Sporothrix schenckii, a dimorphic organism found in soil, decaying vegetation, and organic matter. Infection typically occurs through traumatic inoculation into the skin, such as via thorns or splinters, or through animal scratches—particularly from cats. Less commonly, inhalation of fungal spores can lead to pulmonary disease. The condition is classically associated with occupational exposure among farmers, gardeners, and forestry workers, and is more severe in immunocompromised individuals.
The most common form is lymphocutaneous sporotrichosis, which begins as a painless papule at the site of inoculation that gradually enlarges into a nodule and may ulcerate. Over time, additional nodular lesions develop along the draining lymphatic channels, forming a characteristic chain-like pattern. These lesions are typically nonpurulent and only mildly painful, and systemic symptoms are usually absent. A fixed cutaneous form may also occur, presenting as a localized plaque or verrucous lesion without lymphatic spread.
More severe disease occurs in extracutaneous forms, particularly in immunocompromised patients. Osteoarticular sporotrichosis presents as a chronic, indolent infection involving joints such as the knee, wrist, or elbow, often mimicking other causes of arthritis. Pulmonary sporotrichosis resembles tuberculosis, with symptoms including cough, fever, weight loss, and hemoptysis, and can be fatal if untreated. Disseminated disease may involve multiple organ systems, including skin, bones, central nervous system, and eyes, and is associated with significant morbidity and mortality.
Diagnosis relies on isolating the organism from clinical specimens such as tissue biopsy, aspirate, sputum, or synovial fluid. Histologic examination may reveal characteristic “cigar-shaped” yeast forms, although cultures remain the gold standard. Routine blood tests are not particularly helpful in cutaneous disease but may assist in evaluating systemic involvement. Imaging studies are guided by clinical presentation, such as chest radiographs in pulmonary disease or bone scans in suspected disseminated infection.
Treatment depends on the severity and extent of disease. For cutaneous and lymphocutaneous forms, oral itraconazole is the treatment of choice and is continued for several weeks after lesion resolution. Alternatives include terbinafine or saturated potassium iodide solution, although the latter is less well tolerated. Local heat therapy may be used in selected patients who cannot tolerate medications. More severe infections, including pulmonary, osteoarticular, and disseminated forms, require prolonged antifungal therapy, often starting with amphotericin B followed by itraconazole. Immunocompromised patients, particularly those with HIV, may require long-term suppressive therapy.
Patients with localized cutaneous disease can usually be managed as outpatients, whereas those with systemic involvement or immunosuppression require hospital admission and specialist care. Early recognition is important, as delayed diagnosis—especially in disseminated disease—can lead to poor outcomes. A key clinical clue is a history of exposure to soil, plant material, or cats in combination with nodular skin lesions tracking along lymphatics.
Sporotrichosis is a subacute or chronic fungal infection caused by Sporothrix schenckii, a dimorphic organism found in soil, decaying vegetation, and organic matter. Infection typically occurs through traumatic inoculation into the skin, such as via thorns or splinters, or through animal scratches—particularly from cats. Less commonly, inhalation of fungal spores can lead to pulmonary disease. The condition is classically associated with occupational exposure among farmers, gardeners, and forestry workers, and is more severe in immunocompromised individuals.
The most common form is lymphocutaneous sporotrichosis, which begins as a painless papule at the site of inoculation that gradually enlarges into a nodule and may ulcerate. Over time, additional nodular lesions develop along the draining lymphatic channels, forming a characteristic chain-like pattern. These lesions are typically nonpurulent and only mildly painful, and systemic symptoms are usually absent. A fixed cutaneous form may also occur, presenting as a localized plaque or verrucous lesion without lymphatic spread.
More severe disease occurs in extracutaneous forms, particularly in immunocompromised patients. Osteoarticular sporotrichosis presents as a chronic, indolent infection involving joints such as the knee, wrist, or elbow, often mimicking other causes of arthritis. Pulmonary sporotrichosis resembles tuberculosis, with symptoms including cough, fever, weight loss, and hemoptysis, and can be fatal if untreated. Disseminated disease may involve multiple organ systems, including skin, bones, central nervous system, and eyes, and is associated with significant morbidity and mortality.
Diagnosis relies on isolating the organism from clinical specimens such as tissue biopsy, aspirate, sputum, or synovial fluid. Histologic examination may reveal characteristic “cigar-shaped” yeast forms, although cultures remain the gold standard. Routine blood tests are not particularly helpful in cutaneous disease but may assist in evaluating systemic involvement. Imaging studies are guided by clinical presentation, such as chest radiographs in pulmonary disease or bone scans in suspected disseminated infection.
Treatment depends on the severity and extent of disease. For cutaneous and lymphocutaneous forms, oral itraconazole is the treatment of choice and is continued for several weeks after lesion resolution. Alternatives include terbinafine or saturated potassium iodide solution, although the latter is less well tolerated. Local heat therapy may be used in selected patients who cannot tolerate medications. More severe infections, including pulmonary, osteoarticular, and disseminated forms, require prolonged antifungal therapy, often starting with amphotericin B followed by itraconazole. Immunocompromised patients, particularly those with HIV, may require long-term suppressive therapy.
Patients with localized cutaneous disease can usually be managed as outpatients, whereas those with systemic involvement or immunosuppression require hospital admission and specialist care. Early recognition is important, as delayed diagnosis—especially in disseminated disease—can lead to poor outcomes. A key clinical clue is a history of exposure to soil, plant material, or cats in combination with nodular skin lesions tracking along lymphatics.
- Published on
Emergency and Acute Medicine – Smoke Inhalation
Smoke inhalation should be suspected in any patient exposed to fire in an enclosed space or with a history of loss of consciousness. It can cause injury through three main mechanisms: direct thermal injury to the upper airway, chemical irritation of the lower airway, and systemic toxicity from inhaled substances such as carbon monoxide and hydrogen cyanide. Notably, steam inhalation is especially dangerous due to its extremely high heat-carrying capacity, which can rapidly cause severe airway edema and obstruction.
Thermal injury is typically limited to supraglottic structures because the upper airway dissipates heat effectively. However, inhaled irritants can damage lower airway structures, leading to bronchospasm, inflammation, and impaired gas exchange. Systemic toxicity occurs when gases like carbon monoxide impair oxygen delivery or cyanide disrupts cellular respiration.
Patients often present with a history of smoke exposure, especially in confined spaces. Early symptoms may be mild or even absent, with deterioration occurring over the next 24 hours. Upper airway findings include hoarseness, stridor, cough, and nasopharyngeal irritation. Lower airway involvement may present with chest discomfort, hemoptysis, bronchospasm, and excessive secretions. Classic warning signs of significant inhalation injury include facial burns, singed nasal hairs, and carbonaceous sputum.
Evaluation includes pulse oximetry, though it may be falsely normal in carbon monoxide poisoning. Arterial blood gas analysis may reveal hypoxia or metabolic acidosis, particularly in cases of carbon monoxide or cyanide toxicity. Chest radiographs are often initially normal but may show pulmonary changes later. Laboratory testing should include carboxyhemoglobin levels for suspected carbon monoxide exposure and lactate as a marker for cyanide toxicity. Cyanide levels can be measured but treatment should not be delayed while awaiting results.
Management begins with immediate administration of 100% oxygen via face mask. Early intubation is critical in patients with signs of airway compromise such as stridor, drooling, respiratory distress, or altered mental status. Bronchospasm can be treated with nebulized bronchodilators such as albuterol, and corticosteroids may be considered in patients with underlying asthma or COPD.
For carbon monoxide toxicity, treatment includes high-flow oxygen and, in selected cases, hyperbaric oxygen therapy. Cyanide toxicity should be treated promptly with hydroxocobalamin (preferred), or with sodium thiosulfate if necessary. Care must be taken with nitrite-based antidotes in patients with concurrent carbon monoxide exposure.
Patients requiring intubation, those with significant burns, persistent respiratory symptoms, or evidence of toxic exposure should be admitted. Patients with minimal exposure who remain asymptomatic after a period of observation (typically 4–6 hours) may be discharged with clear return precautions.
Key points include maintaining a high index of suspicion even with initially normal findings, recognizing that pulse oximetry can be misleading, initiating early oxygen therapy, and not delaying treatment for suspected cyanide toxicity.
Smoke inhalation should be suspected in any patient exposed to fire in an enclosed space or with a history of loss of consciousness. It can cause injury through three main mechanisms: direct thermal injury to the upper airway, chemical irritation of the lower airway, and systemic toxicity from inhaled substances such as carbon monoxide and hydrogen cyanide. Notably, steam inhalation is especially dangerous due to its extremely high heat-carrying capacity, which can rapidly cause severe airway edema and obstruction.
Thermal injury is typically limited to supraglottic structures because the upper airway dissipates heat effectively. However, inhaled irritants can damage lower airway structures, leading to bronchospasm, inflammation, and impaired gas exchange. Systemic toxicity occurs when gases like carbon monoxide impair oxygen delivery or cyanide disrupts cellular respiration.
Patients often present with a history of smoke exposure, especially in confined spaces. Early symptoms may be mild or even absent, with deterioration occurring over the next 24 hours. Upper airway findings include hoarseness, stridor, cough, and nasopharyngeal irritation. Lower airway involvement may present with chest discomfort, hemoptysis, bronchospasm, and excessive secretions. Classic warning signs of significant inhalation injury include facial burns, singed nasal hairs, and carbonaceous sputum.
Evaluation includes pulse oximetry, though it may be falsely normal in carbon monoxide poisoning. Arterial blood gas analysis may reveal hypoxia or metabolic acidosis, particularly in cases of carbon monoxide or cyanide toxicity. Chest radiographs are often initially normal but may show pulmonary changes later. Laboratory testing should include carboxyhemoglobin levels for suspected carbon monoxide exposure and lactate as a marker for cyanide toxicity. Cyanide levels can be measured but treatment should not be delayed while awaiting results.
Management begins with immediate administration of 100% oxygen via face mask. Early intubation is critical in patients with signs of airway compromise such as stridor, drooling, respiratory distress, or altered mental status. Bronchospasm can be treated with nebulized bronchodilators such as albuterol, and corticosteroids may be considered in patients with underlying asthma or COPD.
For carbon monoxide toxicity, treatment includes high-flow oxygen and, in selected cases, hyperbaric oxygen therapy. Cyanide toxicity should be treated promptly with hydroxocobalamin (preferred), or with sodium thiosulfate if necessary. Care must be taken with nitrite-based antidotes in patients with concurrent carbon monoxide exposure.
Patients requiring intubation, those with significant burns, persistent respiratory symptoms, or evidence of toxic exposure should be admitted. Patients with minimal exposure who remain asymptomatic after a period of observation (typically 4–6 hours) may be discharged with clear return precautions.
Key points include maintaining a high index of suspicion even with initially normal findings, recognizing that pulse oximetry can be misleading, initiating early oxygen therapy, and not delaying treatment for suspected cyanide toxicity.
- Published on
Emergency and Acute Medicine – Snake Envenomation
Snake envenomation is a medical emergency caused by the injection of venom, most commonly from pit vipers, which contain proteolytic enzymes and thrombin-like substances. These toxins cause local tissue destruction and systemic coagulopathy known as venom-induced consumption coagulopathy (VICC). While extremity bites are most common, bites to the head, neck, or trunk are more severe. Notably, up to 25% of pit viper bites are “dry bites” and do not result in envenomation.
In the United States, pit vipers (rattlesnakes, copperheads, and cottonmouths) account for the vast majority of envenomations. Coral snakes, though less common, produce primarily neurotoxic venom. International and exotic snakes may also be encountered, particularly in zoos or private collections. Children are at higher risk for severe toxicity due to smaller body mass.
Local symptoms of pit viper bites typically include one or two puncture wounds, immediate pain, swelling, and progressive edema. Over time, ecchymosis, petechiae, and hemorrhagic blisters may develop. Regional lymphadenopathy is common. Systemic symptoms may include weakness, nausea, diaphoresis, metallic taste, and neurologic findings such as paresthesias or fasciculations. Severe envenomation can lead to coagulopathy, hypotension, pulmonary edema, kidney injury, and cardiac dysfunction. Coral snake envenomation may initially show minimal local findings but can cause delayed neurologic symptoms such as weakness, diplopia, and respiratory failure.
Evaluation requires careful and repeated physical examination, including marking the margins of swelling to monitor progression. Laboratory studies include CBC, coagulation profile, fibrinogen, electrolytes, renal function, creatine phosphokinase, and urinalysis. These help assess severity and complications such as coagulopathy or rhabdomyolysis.
Prehospital care focuses on safety and supportive measures. The patient should move away from the snake, minimize activity, and keep the affected limb immobilized at heart level. Constrictive items should be removed. Harmful interventions such as incision, suction, tourniquets, cryotherapy, or electrical treatment should be avoided, as they worsen outcomes.
Initial management in the emergency setting follows airway, breathing, and circulation principles, along with fluid resuscitation to maintain renal perfusion. Pain is managed with IV opioids. Tetanus prophylaxis should be updated, but routine antibiotics and steroids are not indicated unless treating antivenom reactions.
Antivenom is the cornerstone of treatment for significant envenomation. Indications include progressive swelling, systemic toxicity, coagulopathy, or unstable vital signs. CroFab is the primary treatment for North American pit viper envenomation. Initial dosing is typically 4–6 vials IV, with higher doses for severe cases. Response is assessed after infusion, and additional or maintenance dosing may be required. Pediatric patients receive the same dosing as adults.
Patients must be monitored closely for allergic reactions to antivenom. If reactions occur, treatment includes antihistamines, corticosteroids, fluids, and epinephrine if severe. Decisions about restarting antivenom should involve a toxicologist or poison control center.
Patients with moderate to severe envenomation or those receiving antivenom require admission, often to the ICU. Even asymptomatic patients with potentially venomous bites should be observed for several hours. Discharge is appropriate only if there are no signs of envenomation after observation and laboratory evaluation remains normal.
Key points include avoiding harmful first-aid measures, recognizing that symptoms may initially be mild, administering antivenom promptly when indicated, and ensuring close monitoring for progression or complications.
Snake envenomation is a medical emergency caused by the injection of venom, most commonly from pit vipers, which contain proteolytic enzymes and thrombin-like substances. These toxins cause local tissue destruction and systemic coagulopathy known as venom-induced consumption coagulopathy (VICC). While extremity bites are most common, bites to the head, neck, or trunk are more severe. Notably, up to 25% of pit viper bites are “dry bites” and do not result in envenomation.
In the United States, pit vipers (rattlesnakes, copperheads, and cottonmouths) account for the vast majority of envenomations. Coral snakes, though less common, produce primarily neurotoxic venom. International and exotic snakes may also be encountered, particularly in zoos or private collections. Children are at higher risk for severe toxicity due to smaller body mass.
Local symptoms of pit viper bites typically include one or two puncture wounds, immediate pain, swelling, and progressive edema. Over time, ecchymosis, petechiae, and hemorrhagic blisters may develop. Regional lymphadenopathy is common. Systemic symptoms may include weakness, nausea, diaphoresis, metallic taste, and neurologic findings such as paresthesias or fasciculations. Severe envenomation can lead to coagulopathy, hypotension, pulmonary edema, kidney injury, and cardiac dysfunction. Coral snake envenomation may initially show minimal local findings but can cause delayed neurologic symptoms such as weakness, diplopia, and respiratory failure.
Evaluation requires careful and repeated physical examination, including marking the margins of swelling to monitor progression. Laboratory studies include CBC, coagulation profile, fibrinogen, electrolytes, renal function, creatine phosphokinase, and urinalysis. These help assess severity and complications such as coagulopathy or rhabdomyolysis.
Prehospital care focuses on safety and supportive measures. The patient should move away from the snake, minimize activity, and keep the affected limb immobilized at heart level. Constrictive items should be removed. Harmful interventions such as incision, suction, tourniquets, cryotherapy, or electrical treatment should be avoided, as they worsen outcomes.
Initial management in the emergency setting follows airway, breathing, and circulation principles, along with fluid resuscitation to maintain renal perfusion. Pain is managed with IV opioids. Tetanus prophylaxis should be updated, but routine antibiotics and steroids are not indicated unless treating antivenom reactions.
Antivenom is the cornerstone of treatment for significant envenomation. Indications include progressive swelling, systemic toxicity, coagulopathy, or unstable vital signs. CroFab is the primary treatment for North American pit viper envenomation. Initial dosing is typically 4–6 vials IV, with higher doses for severe cases. Response is assessed after infusion, and additional or maintenance dosing may be required. Pediatric patients receive the same dosing as adults.
Patients must be monitored closely for allergic reactions to antivenom. If reactions occur, treatment includes antihistamines, corticosteroids, fluids, and epinephrine if severe. Decisions about restarting antivenom should involve a toxicologist or poison control center.
Patients with moderate to severe envenomation or those receiving antivenom require admission, often to the ICU. Even asymptomatic patients with potentially venomous bites should be observed for several hours. Discharge is appropriate only if there are no signs of envenomation after observation and laboratory evaluation remains normal.
Key points include avoiding harmful first-aid measures, recognizing that symptoms may initially be mild, administering antivenom promptly when indicated, and ensuring close monitoring for progression or complications.
- Published on
Emergency and Acute Medicine – Black Widow Spider Bite
Black widow spider envenomation is a neurotoxic syndrome caused primarily by the female spider, whose venom contains α-latrotoxin. This toxin triggers massive neurotransmitter release at nerve terminals, leading to widespread neurologic, muscular, and autonomic effects. Although rarely fatal, severity depends on factors such as patient age, comorbidities (especially cardiovascular disease), number of bites, and location of envenomation. Children and elderly patients are at higher risk for severe complications.
Black widow spiders are glossy black with a characteristic red hourglass marking on the underside of the abdomen. They are commonly found in dark, sheltered environments such as garages, woodpiles, and barns, and bites often occur during warmer months.
The bite itself may feel like a mild pinprick or go unnoticed. Within minutes, local pain develops, often described as sharp or burning, and may spread proximally. Systemic symptoms typically begin within 15–60 minutes and include severe muscle cramps and spasms, which may involve the abdomen, chest, or limbs depending on the bite location. Patients may also experience headache, dizziness, diaphoresis, nausea, vomiting, chest pain, shortness of breath, and anxiety or a sense of impending doom. In severe cases, complications include hypertension, cardiac dysrhythmias, pulmonary edema, respiratory failure, seizures, and priapism.
On examination, vital signs may show hypertension, tachycardia, or fever. A classic local finding is a “target lesion” with two puncture marks, surrounding erythema, and localized sweating. Neuromuscular findings include muscle rigidity, fasciculations, and tetanic contractions. Abdominal rigidity may mimic an acute surgical abdomen, making diagnosis challenging.
Diagnosis is primarily clinical, based on symptoms and history, as laboratory tests are nonspecific. Labs may show mild leukocytosis or elevated creatine kinase due to muscle injury. ECG monitoring is recommended in patients with cardiac symptoms or risk factors. Imaging may be needed to exclude other causes of abdominal or chest pain.
Management begins with supportive care. The wound should be cleaned, and tetanus prophylaxis administered. Pain control is essential, typically with opioids, and muscle spasms are treated with benzodiazepines. Antiemetics and antihistamines may be used for associated symptoms. Severe hypertension may require antihypertensive therapy.
Antivenin is reserved for moderate to severe cases that do not respond to supportive treatment or for high-risk patients, including pregnant individuals. Indications include severe pain, hypertension, respiratory distress, seizures, or persistent symptoms. The antivenin is effective and usually produces rapid improvement but carries a risk of hypersensitivity reactions, particularly because it is derived from horse serum. Patients must be monitored closely for anaphylaxis, and pretreatment with antihistamines or epinephrine may be considered.
Admission is recommended for patients with significant symptoms, high-risk groups (children, elderly, pregnant), or those requiring antivenin. Asymptomatic patients may be observed for several hours and discharged if no symptoms develop. Most symptoms peak within a few hours and resolve within 2–3 days, though some patients may experience prolonged fatigue, weakness, or neurologic symptoms.
Key points include recognizing the characteristic muscle cramps and autonomic symptoms, distinguishing the condition from surgical emergencies, providing aggressive symptomatic treatment, and using antivenin appropriately in severe cases.
Black widow spider envenomation is a neurotoxic syndrome caused primarily by the female spider, whose venom contains α-latrotoxin. This toxin triggers massive neurotransmitter release at nerve terminals, leading to widespread neurologic, muscular, and autonomic effects. Although rarely fatal, severity depends on factors such as patient age, comorbidities (especially cardiovascular disease), number of bites, and location of envenomation. Children and elderly patients are at higher risk for severe complications.
Black widow spiders are glossy black with a characteristic red hourglass marking on the underside of the abdomen. They are commonly found in dark, sheltered environments such as garages, woodpiles, and barns, and bites often occur during warmer months.
The bite itself may feel like a mild pinprick or go unnoticed. Within minutes, local pain develops, often described as sharp or burning, and may spread proximally. Systemic symptoms typically begin within 15–60 minutes and include severe muscle cramps and spasms, which may involve the abdomen, chest, or limbs depending on the bite location. Patients may also experience headache, dizziness, diaphoresis, nausea, vomiting, chest pain, shortness of breath, and anxiety or a sense of impending doom. In severe cases, complications include hypertension, cardiac dysrhythmias, pulmonary edema, respiratory failure, seizures, and priapism.
On examination, vital signs may show hypertension, tachycardia, or fever. A classic local finding is a “target lesion” with two puncture marks, surrounding erythema, and localized sweating. Neuromuscular findings include muscle rigidity, fasciculations, and tetanic contractions. Abdominal rigidity may mimic an acute surgical abdomen, making diagnosis challenging.
Diagnosis is primarily clinical, based on symptoms and history, as laboratory tests are nonspecific. Labs may show mild leukocytosis or elevated creatine kinase due to muscle injury. ECG monitoring is recommended in patients with cardiac symptoms or risk factors. Imaging may be needed to exclude other causes of abdominal or chest pain.
Management begins with supportive care. The wound should be cleaned, and tetanus prophylaxis administered. Pain control is essential, typically with opioids, and muscle spasms are treated with benzodiazepines. Antiemetics and antihistamines may be used for associated symptoms. Severe hypertension may require antihypertensive therapy.
Antivenin is reserved for moderate to severe cases that do not respond to supportive treatment or for high-risk patients, including pregnant individuals. Indications include severe pain, hypertension, respiratory distress, seizures, or persistent symptoms. The antivenin is effective and usually produces rapid improvement but carries a risk of hypersensitivity reactions, particularly because it is derived from horse serum. Patients must be monitored closely for anaphylaxis, and pretreatment with antihistamines or epinephrine may be considered.
Admission is recommended for patients with significant symptoms, high-risk groups (children, elderly, pregnant), or those requiring antivenin. Asymptomatic patients may be observed for several hours and discharged if no symptoms develop. Most symptoms peak within a few hours and resolve within 2–3 days, though some patients may experience prolonged fatigue, weakness, or neurologic symptoms.
Key points include recognizing the characteristic muscle cramps and autonomic symptoms, distinguishing the condition from surgical emergencies, providing aggressive symptomatic treatment, and using antivenin appropriately in severe cases.
- Published on
Emergency and Acute Medicine: Spider Bite – Brown Recluse (Loxoscelism)
Brown recluse spider envenomation causes a spectrum of illness ranging from localized skin injury to systemic toxicity, a condition known as loxoscelism. Most patients develop a cutaneous lesion, but in some cases—particularly in children—the venom can produce significant systemic effects such as hemolysis, renal failure, or coagulopathy. The disease results from the toxic effects of enzymes within the venom that trigger inflammation, tissue destruction, and vascular injury.
The brown recluse, also known as the fiddleback spider, is a small tan-to-brown spider with a distinctive violin-shaped marking on its back and three pairs of eyes. It typically inhabits warm, dry environments such as woodpiles, attics, closets, and storage areas. Bites usually occur when the spider is trapped against the skin, making them defensive in nature. The venom contains enzymes that bind to red blood cells causing hemolysis, activate inflammatory pathways through complement, and induce tissue necrosis by lipolysis. It also promotes platelet aggregation and thrombosis, and in severe cases may lead to disseminated intravascular coagulation or shock. The severity of toxicity depends on the amount of venom, the size of the patient, and the location of the bite, with children being more susceptible to severe outcomes.
Clinically, diagnosis relies on a combination of presentation and history, although a confirmed spider bite is often difficult to establish. Most patients present with a single skin lesion, commonly in areas where clothing traps the spider. The bite is often initially painless, but within hours patients may develop burning, itching, or aching at the site. Over time, the lesion evolves into a characteristic pattern with a red outer zone, a pale ischemic ring, and a central area of bluish or purple discoloration indicating necrosis. Blisters may form within 24 to 72 hours, followed by the development of a necrotic eschar over several days. The eschar eventually sloughs, leaving an ulcer that heals slowly over weeks and may result in scarring. The extent of local tissue damage does not reliably predict systemic toxicity.
Systemic manifestations are uncommon but more likely in children and typically develop within one to three days after envenomation. Patients may experience fever, malaise, nausea, vomiting, muscle pain, and jaundice due to hemolysis. A generalized rash, dark urine, and signs of hemoglobinuria may also occur. Severe cases can progress to acute kidney injury, disseminated intravascular coagulation, and shock.
Evaluation is primarily clinical, and laboratory testing is not required in mild cases. However, if systemic toxicity is suspected, investigations may reveal hemolytic anemia, thrombocytopenia, leukocytosis, and abnormalities in coagulation consistent with DIC. Renal function tests may indicate impairment, and urinalysis may show hemoglobinuria or proteinuria. Imaging is generally reserved for complications.
It is important to consider alternative diagnoses, as brown recluse bites are frequently overdiagnosed. Conditions such as bacterial skin infections (including MRSA), necrotizing fasciitis, diabetic ulcers, vasculitis, fungal infections, and other dermatologic or vascular disorders can mimic the presentation. In the absence of a clear history of a spider bite, these alternatives should be strongly considered.
Management is largely supportive. Prehospital care includes immobilizing and elevating the affected limb and applying cool compresses. Harmful measures such as incision, suction, or tourniquets should be avoided. In the emergency setting, treatment involves wound cleansing, tetanus prophylaxis, and adequate analgesia. Antibiotics are indicated only if there is evidence of secondary infection. Early surgical excision is contraindicated, as it may worsen tissue injury.
In cases with systemic involvement, management includes intravenous fluids, monitoring of renal and hematologic parameters, and supportive care such as blood transfusions for severe hemolysis or coagulopathy. Dialysis may be required for renal failure, and vasopressors may be needed in cases of shock. The use of dapsone is controversial and should only be considered in severe cases after screening for G6PD deficiency due to the risk of hemolysis and methemoglobinemia. There is no widely available antivenom.
Patients with significant local progression, systemic toxicity, or high-risk features—especially children—should be admitted for monitoring and treatment. Those with mild, stable lesions may be discharged with close follow-up and reassessment over the next several days. Patients should be counseled about the prolonged healing process and the possibility of scarring, with surgical intervention typically delayed until the acute phase has resolved.
Brown recluse bites are relatively uncommon, and overdiagnosis is a frequent pitfall. Many suspected cases are actually due to infections or other causes of necrotic skin lesions. Careful clinical evaluation, avoidance of unnecessary interventions, and appropriate monitoring are essential to achieving good outcomes.
- Published on
Emergency and Acute Medicine: Spinal Cord Syndromes
Spinal cord syndromes represent patterns of neurologic deficits caused by localized disruption of spinal cord pathways, most commonly due to trauma. These injuries produce characteristic combinations of motor and sensory loss depending on the portion of the cord affected. While high-energy trauma is the most frequent cause, patients with underlying spinal disease such as arthritis, osteoporosis, or metastatic lesions are at increased risk of cord injury even after minor trauma.
Several classic syndromes are recognized. Anterior cord syndrome typically results from flexion or axial loading injuries, or from direct compression by fractures, discs, tumors, or abscesses, and occasionally from compromise of the anterior spinal artery. It presents with bilateral motor paralysis and loss of pain and temperature sensation below the lesion, while dorsal column functions (proprioception and vibration) are preserved. Brown-Séquard syndrome results from hemisection of the cord, most often due to penetrating trauma, and produces ipsilateral motor weakness and loss of proprioception, with contralateral loss of pain and temperature, usually beginning a few levels below the injury. Central cord syndrome, commonly seen in elderly patients with cervical spondylosis, follows hyperextension injuries and leads to greater motor weakness in the upper extremities than the lower, with variable sensory deficits. Dorsal cord syndrome involves loss of proprioception, position sense, and coordination, while complete cord syndrome represents total disruption of the cord, resulting in complete motor and sensory loss below the lesion, often accompanied by neurogenic shock characterized by hypotension, bradycardia, warm skin, and sometimes priapism. Deficits that persist beyond 24 hours are usually permanent.
Patients typically present with an acute loss of motor and/or sensory function following trauma. A detailed neurologic examination is essential to determine the level of injury, using known sensory and motor landmarks such as the clavicles (C4), nipples (T4), umbilicus (T10), and perianal region (S5), as well as key motor functions like elbow flexion (C5), finger movement (C8–T1), and ankle motion (L4–S1). Accurate documentation of these findings is critical for diagnosis, monitoring progression, and guiding management.
Evaluation begins with a thorough neurologic assessment and urgent neurosurgical consultation if any deficit is present. Imaging should include plain radiographs of suspected areas, though CT scanning is often preferred, especially in older patients or when radiographs are inconclusive, as it better visualizes bony injury and canal compromise. MRI is the imaging modality of choice for assessing spinal cord injury, particularly when neurologic deficits are unexplained, progressing, or when surgical intervention is being considered. If MRI is unavailable, CT myelography may be used. Additional studies such as lumbar puncture may be considered when alternative diagnoses like demyelinating or inflammatory conditions are suspected.
The differential diagnosis includes peripheral nerve injuries, dorsal root lesions, Guillain–Barré syndrome, multiple sclerosis, transverse myelitis, epidural abscess, and stroke, all of which may mimic spinal cord pathology and must be carefully distinguished.
Management begins in the prehospital setting with strict spinal immobilization and rapid transport to a trauma center. In the emergency department, immobilization must be maintained at all times, including during airway management with in-line stabilization. Intravenous fluids should be administered, particularly in cases of hypotension, though other causes such as hemorrhage must be excluded. Neurogenic shock should be suspected when hypotension is accompanied by bradycardia, and if unresponsive to fluids, vasopressors (preferably alpha-agonists) may be required.
Early involvement of neurosurgery is critical, as timely decompression or stabilization may improve outcomes. Associated injuries should be treated concurrently, and patients with penetrating trauma require antibiotics and tetanus prophylaxis. The routine use of high-dose corticosteroids is no longer recommended, as evidence has not demonstrated clear benefit and may increase complications.
All patients with suspected spinal cord syndromes require hospital admission, typically to an intensive care unit, for close monitoring and management. No patient with signs of spinal cord injury should be discharged from the emergency department. Early recognition, accurate neurologic assessment, and prompt specialist involvement are key factors influencing prognosis and long-term outcomes.
- Published on
Emergency and Acute Medicine: Cervical Spine Injury (Adult)
Cervical spine injury refers to trauma involving the vertebrae, spinal cord, or supporting ligaments of the neck, and may result from one or multiple mechanisms acting simultaneously. These injuries range from stable fractures to highly unstable patterns associated with spinal cord damage. Common mechanisms include flexion, extension, rotation, and axial loading forces, each producing characteristic injury patterns. Flexion injuries may cause wedge fractures, ligamentous disruption, or severe unstable injuries such as flexion teardrop fractures and bilateral facet dislocations. Extension injuries can result in fractures of the posterior elements, including the atlas or axis, and classic injuries such as the hangman fracture. Axial loading may lead to burst fractures or Jefferson fractures of C1, both of which can be highly unstable.
Blunt trauma is the leading cause of cervical spine injuries, with motor vehicle accidents accounting for the majority, followed by falls and sports-related injuries. Patients with pre-existing spinal conditions such as ankylosing spondylitis, osteoporosis, or metastatic disease are particularly vulnerable, as even minor trauma can result in significant injury. Penetrating trauma may also cause cervical spine damage, especially when associated with neurologic deficits.
Patients typically present with neck pain and tenderness, often accompanied by neurologic symptoms such as numbness, weakness, or paresthesias in the upper or lower extremities. However, a cervical spine injury must be assumed in any trauma patient with altered mental status, intoxication, inability to communicate, distracting injuries, or significant head and neck trauma, even in the absence of pain. Physical examination should include careful inspection for deformity or bruising, palpation of the cervical spine, and a thorough neurologic assessment of motor, sensory, and reflex function. Associated incomplete spinal cord syndromes such as anterior cord, Brown-Séquard, or central cord syndromes may be present and should be recognized.
Evaluation requires a complete clinical assessment combined with appropriate imaging. Standard imaging traditionally includes three-view cervical spine radiographs (lateral, anteroposterior, and odontoid views), ensuring visualization from C1 to T1. However, CT scanning has become the preferred initial imaging modality, especially in high-risk or obtunded patients, due to its superior sensitivity for detecting fractures and alignment abnormalities. MRI is indicated in patients with neurologic deficits, suspected ligamentous injury, or persistent symptoms despite normal CT, as it is the best modality for evaluating spinal cord and soft tissue injury. Flexion–extension views may be used selectively in alert patients with persistent pain to assess ligamentous stability.
Clinical decision tools such as the NEXUS criteria can help determine which patients require imaging. Patients who are alert, not intoxicated, without midline cervical tenderness, neurologic deficits, or distracting injuries may be safely cleared clinically without imaging. However, strict adherence to all criteria is essential to avoid missed injuries.
Initial management begins with strict spinal immobilization using a rigid cervical collar, backboard, and supportive padding. Airway management must be performed with in-line spinal stabilization, typically using rapid sequence intubation, with alternative airway techniques available if needed. Intravenous access should be established, and circulation supported. In cases of hypotension, clinicians must differentiate between hypovolemic shock and neurogenic shock, the latter characterized by hypotension with bradycardia due to loss of sympathetic tone.
In the emergency department, patients should be evaluated for associated injuries, as cervical spine trauma often occurs in the context of multisystem trauma. If imaging reveals fractures, dislocations, or instability, or if neurologic deficits are present, urgent consultation with neurosurgery or orthopedic spine specialists is required. Patients with persistent pain despite normal imaging may require further evaluation with MRI or dynamic studies. Historically, high-dose corticosteroids such as methylprednisolone were used in spinal cord injury, but current evidence does not support routine use, and their role remains controversial.
All patients with confirmed cervical spine fractures, dislocations, or neurologic deficits require hospital admission, often to an intensive care or monitored setting. Stable injuries without neurologic compromise may still require admission for observation and specialist management. Patients with minor soft tissue injuries such as whiplash and normal imaging may be discharged with appropriate follow-up and instructions to return if symptoms worsen.
A key pitfall is underestimating injury severity, particularly in patients with underlying spinal disease, where seemingly minor trauma can result in significant instability or cord injury. Strict application of clinical decision rules and a high index of suspicion are essential. Careful neurologic assessment, appropriate imaging, and early specialist involvement are critical to optimizing outcomes and preventing long-term disability.
Cervical spine injury refers to trauma involving the vertebrae, spinal cord, or supporting ligaments of the neck, and may result from one or multiple mechanisms acting simultaneously. These injuries range from stable fractures to highly unstable patterns associated with spinal cord damage. Common mechanisms include flexion, extension, rotation, and axial loading forces, each producing characteristic injury patterns. Flexion injuries may cause wedge fractures, ligamentous disruption, or severe unstable injuries such as flexion teardrop fractures and bilateral facet dislocations. Extension injuries can result in fractures of the posterior elements, including the atlas or axis, and classic injuries such as the hangman fracture. Axial loading may lead to burst fractures or Jefferson fractures of C1, both of which can be highly unstable.
Blunt trauma is the leading cause of cervical spine injuries, with motor vehicle accidents accounting for the majority, followed by falls and sports-related injuries. Patients with pre-existing spinal conditions such as ankylosing spondylitis, osteoporosis, or metastatic disease are particularly vulnerable, as even minor trauma can result in significant injury. Penetrating trauma may also cause cervical spine damage, especially when associated with neurologic deficits.
Patients typically present with neck pain and tenderness, often accompanied by neurologic symptoms such as numbness, weakness, or paresthesias in the upper or lower extremities. However, a cervical spine injury must be assumed in any trauma patient with altered mental status, intoxication, inability to communicate, distracting injuries, or significant head and neck trauma, even in the absence of pain. Physical examination should include careful inspection for deformity or bruising, palpation of the cervical spine, and a thorough neurologic assessment of motor, sensory, and reflex function. Associated incomplete spinal cord syndromes such as anterior cord, Brown-Séquard, or central cord syndromes may be present and should be recognized.
Evaluation requires a complete clinical assessment combined with appropriate imaging. Standard imaging traditionally includes three-view cervical spine radiographs (lateral, anteroposterior, and odontoid views), ensuring visualization from C1 to T1. However, CT scanning has become the preferred initial imaging modality, especially in high-risk or obtunded patients, due to its superior sensitivity for detecting fractures and alignment abnormalities. MRI is indicated in patients with neurologic deficits, suspected ligamentous injury, or persistent symptoms despite normal CT, as it is the best modality for evaluating spinal cord and soft tissue injury. Flexion–extension views may be used selectively in alert patients with persistent pain to assess ligamentous stability.
Clinical decision tools such as the NEXUS criteria can help determine which patients require imaging. Patients who are alert, not intoxicated, without midline cervical tenderness, neurologic deficits, or distracting injuries may be safely cleared clinically without imaging. However, strict adherence to all criteria is essential to avoid missed injuries.
Initial management begins with strict spinal immobilization using a rigid cervical collar, backboard, and supportive padding. Airway management must be performed with in-line spinal stabilization, typically using rapid sequence intubation, with alternative airway techniques available if needed. Intravenous access should be established, and circulation supported. In cases of hypotension, clinicians must differentiate between hypovolemic shock and neurogenic shock, the latter characterized by hypotension with bradycardia due to loss of sympathetic tone.
In the emergency department, patients should be evaluated for associated injuries, as cervical spine trauma often occurs in the context of multisystem trauma. If imaging reveals fractures, dislocations, or instability, or if neurologic deficits are present, urgent consultation with neurosurgery or orthopedic spine specialists is required. Patients with persistent pain despite normal imaging may require further evaluation with MRI or dynamic studies. Historically, high-dose corticosteroids such as methylprednisolone were used in spinal cord injury, but current evidence does not support routine use, and their role remains controversial.
All patients with confirmed cervical spine fractures, dislocations, or neurologic deficits require hospital admission, often to an intensive care or monitored setting. Stable injuries without neurologic compromise may still require admission for observation and specialist management. Patients with minor soft tissue injuries such as whiplash and normal imaging may be discharged with appropriate follow-up and instructions to return if symptoms worsen.
A key pitfall is underestimating injury severity, particularly in patients with underlying spinal disease, where seemingly minor trauma can result in significant instability or cord injury. Strict application of clinical decision rules and a high index of suspicion are essential. Careful neurologic assessment, appropriate imaging, and early specialist involvement are critical to optimizing outcomes and preventing long-term disability.
- Published on
Emergency and Acute Medicine: Sternoclavicular Joint Injury
The sternoclavicular joint (SCJ) is the only articulation connecting the upper limb to the axial skeleton, making it a critical but relatively uncommon site of injury. Stability of this joint depends largely on surrounding ligaments, including the anterior and posterior sternoclavicular ligaments, interclavicular ligament, and costoclavicular ligament. Injuries to the SCJ are rare and typically result from high-energy trauma such as motor vehicle collisions or athletic impacts. They may present as sprains, subluxations, or complete dislocations.
SCJ injuries occur when ligamentous structures are stressed or disrupted. In sprains, the joint capsule remains intact, while subluxation involves partial ligament rupture with preserved costoclavicular support. Complete ligament disruption leads to dislocation, which may be anterior or posterior depending on the direction of force and shoulder position at the time of injury. Anterior dislocations are far more common, accounting for over 90% of cases, and typically result from a posteriorly directed force to the shoulder. Posterior dislocations are less common but far more dangerous, often resulting from direct trauma to the medial clavicle or force transmitted through the shoulder. These can compress vital mediastinal structures, including the trachea, esophagus, and major vessels, making them surgical emergencies.
Patients usually present with localized pain and swelling over the medial clavicle, often holding the affected arm across the chest. Movement of the shoulder is limited, particularly abduction and external rotation. In anterior dislocations, the medial clavicle is visibly prominent and palpable. Posterior dislocations may be more difficult to detect due to swelling but may present with concerning symptoms such as difficulty breathing or swallowing, hoarseness, or signs of vascular compromise. A thorough neurovascular and airway assessment is essential in all suspected cases.
Diagnosis can be challenging with plain radiographs, as the SCJ is poorly visualized. Chest x-rays may appear normal, so a high index of suspicion is required. CT scanning is the imaging modality of choice, as it clearly defines the position of the clavicle and can identify associated injuries to surrounding structures. Ultrasound may be useful in the emergency setting, particularly in unstable patients, while MRI can provide additional detail regarding soft tissue and ligamentous injuries.
Management depends on the severity and type of injury. Sprains and subluxations are typically treated conservatively with rest, analgesia, and sling immobilization. Anterior dislocations may be reduced in the emergency department using traction and positioning techniques under procedural sedation, though recurrence is common and residual deformity is usually cosmetic. Posterior dislocations, however, require urgent reduction—preferably in the operating room with orthopedic and thoracic surgical support due to the risk of life-threatening complications. In emergencies where airway or vascular compromise is present and surgical support is unavailable, reduction may need to be attempted in the ED.
Patients with posterior dislocations or associated complications require hospital admission for monitoring and further management. Those with uncomplicated anterior dislocations or minor injuries may be discharged with appropriate immobilization and close orthopedic follow-up. Activity restriction is important during recovery, and high-risk activities should be avoided for several months.
A key pitfall is missing posterior dislocations, which may be mistaken for anterior injuries due to swelling. In children, injuries to the growth plate can mimic SCJ dislocations. Because of the potential for severe complications, especially with posterior dislocations, early recognition and specialist involvement are critical for optimal outcomes.
The sternoclavicular joint (SCJ) is the only articulation connecting the upper limb to the axial skeleton, making it a critical but relatively uncommon site of injury. Stability of this joint depends largely on surrounding ligaments, including the anterior and posterior sternoclavicular ligaments, interclavicular ligament, and costoclavicular ligament. Injuries to the SCJ are rare and typically result from high-energy trauma such as motor vehicle collisions or athletic impacts. They may present as sprains, subluxations, or complete dislocations.
SCJ injuries occur when ligamentous structures are stressed or disrupted. In sprains, the joint capsule remains intact, while subluxation involves partial ligament rupture with preserved costoclavicular support. Complete ligament disruption leads to dislocation, which may be anterior or posterior depending on the direction of force and shoulder position at the time of injury. Anterior dislocations are far more common, accounting for over 90% of cases, and typically result from a posteriorly directed force to the shoulder. Posterior dislocations are less common but far more dangerous, often resulting from direct trauma to the medial clavicle or force transmitted through the shoulder. These can compress vital mediastinal structures, including the trachea, esophagus, and major vessels, making them surgical emergencies.
Patients usually present with localized pain and swelling over the medial clavicle, often holding the affected arm across the chest. Movement of the shoulder is limited, particularly abduction and external rotation. In anterior dislocations, the medial clavicle is visibly prominent and palpable. Posterior dislocations may be more difficult to detect due to swelling but may present with concerning symptoms such as difficulty breathing or swallowing, hoarseness, or signs of vascular compromise. A thorough neurovascular and airway assessment is essential in all suspected cases.
Diagnosis can be challenging with plain radiographs, as the SCJ is poorly visualized. Chest x-rays may appear normal, so a high index of suspicion is required. CT scanning is the imaging modality of choice, as it clearly defines the position of the clavicle and can identify associated injuries to surrounding structures. Ultrasound may be useful in the emergency setting, particularly in unstable patients, while MRI can provide additional detail regarding soft tissue and ligamentous injuries.
Management depends on the severity and type of injury. Sprains and subluxations are typically treated conservatively with rest, analgesia, and sling immobilization. Anterior dislocations may be reduced in the emergency department using traction and positioning techniques under procedural sedation, though recurrence is common and residual deformity is usually cosmetic. Posterior dislocations, however, require urgent reduction—preferably in the operating room with orthopedic and thoracic surgical support due to the risk of life-threatening complications. In emergencies where airway or vascular compromise is present and surgical support is unavailable, reduction may need to be attempted in the ED.
Patients with posterior dislocations or associated complications require hospital admission for monitoring and further management. Those with uncomplicated anterior dislocations or minor injuries may be discharged with appropriate immobilization and close orthopedic follow-up. Activity restriction is important during recovery, and high-risk activities should be avoided for several months.
A key pitfall is missing posterior dislocations, which may be mistaken for anterior injuries due to swelling. In children, injuries to the growth plate can mimic SCJ dislocations. Because of the potential for severe complications, especially with posterior dislocations, early recognition and specialist involvement are critical for optimal outcomes.
